A Multi-Center, Randomized, Controlled, Double-Blind Study of the Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis Patients
Purpose: The purpose of this study in Cystic Fibrosis will be to further evaluate the effects of a modified formulation of AquADEKs® (AquADEKs-2) on markers of inflammation, antioxidant levels, and oxidative stress.
Eligibility: You may be eligible if you are over 12 years of age, have cystic fibrosis, and have pancreatic insufficiency.
Sponsor: Cystic Fibrosis Foundation Therapeutics
Principal Investigator: Cori Daines, MD
Osmara Y. Molina de Rodriguez, MS
Cell: (520) 891-6767 or Office: (520) 626-3910